Short answer
BIOLIFE SOLUTIONS INC (BLFS) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $28M (down 8.2% year over year) with net income of $621,000.
Q3 2025 key financials · XBRL
- Revenue
- $28M
- −8.2% YoY · +10.4% QoQ
- Net income
- $621,000
- +136.5% YoY · +103.9% QoQ
- Operating margin
- -0.3%
- EPS (diluted)
- $0.01
- +133.3% YoY · +103.0% QoQ
Source: XBRL data from the BIOLIFE SOLUTIONS INC (BLFS) Q3 2025 10-Q on SEC EDGAR. USD.
BIOLIFE SOLUTIONS INC Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New accounting standards ASU 2025-07, ASU 2025-06, ASU 2025-05, ASU 2025-04, ASU 2025-03 issued by FASB, effective 2026-2028, no expected material impact stated
- Material update: April 2025 acquisition of PanTHERA, $15.5M in-process R&D cost expensed immediately due to no alternative future use
- Regulatory/legal risk: $5.4M total loss contingencies for Global Cooling lawsuits, deemed probable to settle next fiscal year, covered by insurance minus deductibles
- Operational/market risk: Divestiture of Freezer Business segments in 2024, including Global Cooling, SciSafe, and CBS, with divestiture losses totaling $8.9M (Global Cooling), gain $28.1M (SciSafe), loss $3.4M (CBS)
- Financial risk: $7.2M earnout liability contingent on PanTHERA revenue and milestones, probability assessed as remote, so no earnout recognized as of 9/30/25
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other BIOLIFE SOLUTIONS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.